scott gottlieb. the massive aid bill has been torpedoed by the president. his refusal to sign is a putting a staggering amount of financial aid in jeopardy just as struggling americans need it the most. in these final weeks of the trump administration, ironically, it is democrats who are in agreement with mr. trump on his demand for additional payments, which has split the president from most republicans. one thing americans are not divided on? 2020 will go down in history as one of the worst years ever, at least in our lifetime. with political and racial divisions plaguing our society, what can be done to unite the country? we'll have a discussion on race, leadership, and moving forward with our holiday book panel. we'll talk with pulitzer prize winning author and journalist isabel wilkerson. her new book is "cast: the origins of our discontent." his truth is marching on, john lewis and the power of hope is the latest from jon meacham. susan glasser, writer for "the new yorker," and her husband, pet

we played scott gottlieb talking about it just now. but i'm also told by a source that pfizer did offer multiple times for the administration to buy into more doses and the white house declined. what is the white house saying about this? >> reporter: the white house, as you said, is denying they passed up the chance to buy the additional doses. not only does scott gottlieb publicly confirm they did offer them, you have your source as well but moncef slouie indicating he defended the decision not to buy and it wouldn't be reasonable given the candidates we were looking at, it wouldn't have been reasonable to take that process. here's a tip, if the white house is telling you one thing and scott gottlieb and moncef and sl slouie slouie is telling you another thing, believe them. it's possible if you get astrazeneca and the johnson & johnson vaccine also approved for emergency use within a few weeks we may have among all those candidates enough to vaccinate everyone. we don't know if it was a mistake, but we do know they turned down the op

scott gottlieb. he is a cnbc contributor, sits on the boards of united stateser and i will lum in a. your tweet today where you say we have this narrow window or had this narrow window to deploy the vaccine rapidly enough to deploy the trajectory of the disease in january what has gone wrong? the states the federal government the companies? what is happening. >> look, the federal government made a decision to stockpile 55% of the doses they wanted to reserve the second dose for everyone who received the first dose and not use the supply that became available in january to suffice for providing the second doses that people were going to need after getting the first dose then they made an decision to stock bile 5% for a safety stock. so they are deploying 45% of the vaccines that were available and now we are not able to deliver that 45% we had a narrow window of student to use the vaccine as a tool to try to affect the current epidemic the wave we are in is going the play out over the next four to six

scott gottlieb joins us.th us. ♪ ♪ i got it all from you ♪ i'm always pushing through ♪ i know we'll make it to the finish line ♪ ♪ i know you're waiting on the other side ♪ ♪ i'm like you on-demand glucose monitoring. because they're always on. another life-changing technology from abbott. so you don't wait for life. you live it. ♪ ♪ ♪ >> week 14 i in the nfl. >> there is the quarterback of the tennessee titans come 8-4. he has 25 touchdowns, only five pass rushers. >> there is tua tagovailoa, he has won 4 of 5 s

scott gottlieb. gottlieb. don't go away. sit! renew active. only fro♪ lift it althcare. ♪ press it ♪ downward dog it ♪ watch it ♪ sweat it ♪ bend and stretch it ♪ track it ♪ share it ♪ compare it ♪ think it ♪ solve it ♪ try and crack it ♪ breath it ♪ calm it ♪ and renew it renew active from unitedhealthcare gives you so many ways to be healthy. powered by aarp staying sharp and fitbit. and included in unitedhealthcare medicare plans. unitedhealthcare. get medicare with more. [cheering and waving] ♪ [hip hop holiday music plays] ♪ ah, ah! woo! hold on a sec, hold on, hold on, hold on! [gulping water] girl, we didn't even make it to the chorus! woo! that's a lotta dancing, ya'll. ohhh! [laughing] thought it was over! tremfya® can help adults with moderate to severe plaque psoriasis uncover clearer skin that can last. most patients who saw 90% clearer skin at 28 weeks stayed clearer through 48 weeks. in another study, the majority of tremfya® patients saw 90% clearer skin at 3 years. serious allergic reactions may occur. tremfya® may increase you

scott gottlieb, and he joins us from west port, connecticut. good morning to you, doctor.s you know, covid presents many challenges, many of them also technical for live television. so we hope to continue that conversation in a moment. but i'm really glad you're here to answer some of these outstanding questions. on the shear numbers alone, the c.d.c. is predicting about 75,000 more deaths during the first week of january. how much are christmas gatherings going to add to the strain we are seeing on the system right now? >> doctor: we saw a spike coming out of thanksgiving. if you look at the analysis done on a state by state basis, there was anywhere from a 10% to 40% increase in cases. some of that was just the shear magnitude of the virus building. but some of that was a consequence of the gatherings as well, which affected mo more cases. pobably the peak in the number of infections is probably around the first week in january. so we have three more weeks in increasing infections, we'll see a peak in infections and then start to see a decline. but the health care system

scott gottlieb suggested sunday it's likely because they didn't obtain consent in advance from nursing home residents or families to be vaccinated. >> very costly delay, 50,000 new infections in nursing homes every week right now, probably more than that. >> reporter: more than 76,000 residents in long-term care facilities have died from covid-19 and staff members. >> we trust the supplies are getting out quickly. >> reporter: some see cvs and walgreens roll these out as fast and efficient, you're saying bumps down the road. >> i guarantee you. >> reporter: past president of care negotiation. >> the federal government handing distribution of the vaccine for nursing homes to cvs and walgreens was not well thought out. we're anticipating a lot of chaos in the process. >> reporter: last week l.a. county pulled out of the federal vaccine program, instructing nursing facilities to take on their own vaccine administration, a move wasserman encouraged. >> this really needs to be coordinated at the facility level. >> reporter: a senior administration official explained to us that the delay was

you heard what scott gottlieb had to say. is it overstating the case?n is righto on and things will get worse, before they get better. this is the highest rate of infection and death that we have seen and the trajectory suggests things will continue to get worse. not anis somebody who is epidemiologist, we think it has peaked somewhere and then it goes down and then it comes back up. is there a pattern? the upper midwest states are starting to come down? is -- isse is to matt dynamic and driven by our behavior. day, placeing day by by place. what worries us is we are seeing consistently across the u.s. the trend has been going in a direction we don't want there have been local efforts in many different places to try to slow that spread but throughout the country in most places, the trajectory shows continuing increases. that has us alarmed because we're already in a really hot place. david: is that because we are on thetrictive enough rules we are setting out or is it because people are not complying with the rules? as we hear and see, people have gotte

doctor scott gottlieb, former fda commissioner, also talk to us about this and we will look at two others. the economic one as congress continues to argue over what kind of aid relief to provide americans, and san francisco fed president mary daly join us to talk about economic cost of this health crisis and what americans can plan on in terms of further job cuts in 2021. we will get an inside look at the largest cyber attack in united states history. this massive espionage operation that was discovered this week which was revealed by fire i, a private company. their ceo will come on to tell us what they discovered and how far this espionage goes inside the united states government which has been referred to as a grave risk. all of that at 8:30 on kpix 5 . >>> new ways to connect with its audience, the san francisco opera offers three free offer streams in january they can enjoy the show from the comfort of your own chair and kpix 5 alan martin spoke to chip mcneil, san francisco opera director of diversity equity and offered to talk about their romeo and juliet offering. >> one of our m

but a backdrop here is new reporting, and you played that important clip from scott gottlieb, the formerda commissioner under president trump, also a board member on pfizer saying that on multiple occasions the trump administration passed up the opportunity to purchase additional doses of the pfizer vaccine, even according to gottlieb after there were preliminary results showing real promise for that. so the u.s. would wind up buying 100 million vaccines which means it's enough to vaccinate 50 million people because every person needs to get two shots with the pfizer vaccine. the eu, the european union for its part got 200 million vaccines and pfizer has said it may not be until july until they can provide additional doses to the united states. so even as the president will make this statement prioritizing america first as it relates to the vaccine and its distribution, the decision not to purchase additional dosages from pfizer really is putting some countries in other parts of the world ahead of the united states. >> peter, do we have an idea of how many companies, though, we have comm

you wrote an op-ed with form scott gottlieb, former fda commissioner. you told the covid antibody drugs sitting on the shelf, more than 80% of the supply unused. what is going on the treatment side what can we do about it? >> this is a challenge of health care providers having a lot to do at the same time dealing deah the pandemic connell. a million doses of man-made antibodies, same kind of antibodies that you make when you give vaccine, gives you immunity, neutralizes the virus, keeps you from getting serious consequences when you're infected, they can be given. there are very promising studies. the evidence is limited. i think it is pretty important for people who are at high-risk, those over 65, those with chronic conditions, if they get covid, getting treated with these new antibodies before their condition progresses very much. think about what president's trump experience was. he got early version of the antibody treatment. it does look like it is substantially reduces risks of emergency room visits or hospitalizations. the problem is that in ord

scott gottlieb told "face the nation," infections won't peak until january. >> after those infections peak we'll continue to see deaths continue to increase for another three weeks. >> despite the danger, people standing in long lines for last minute holiday gifts, an estimated 150 million shoppers on saturday alone. >> you can pick stuff up, you can price stuff, you can go from one store to the next store. >> a risk too high from those fighting from the front lines including er nurse marcia santini who herself became infectedness we have tro take care of one-- i can't talk. we have to take care of one another. >> many more of those front line workers are getting caught in the astonishing threat of covid. right now it's believed one in 80 people in l.a. county is infected. >> lilia luciannea in los angeles, thank you. >> this weekend some 265,000 wreaths were placed at graves in arlington, national cemetery it happened at indiana's fairview cemetery too. it is part of the volunteer wreaths across america effort to place wreathes at veteran's graves, at some 2100 locations in all 50 st

scott gottlieb as the vice president begins speaking and we'll bring you what he says in just a moment on the board of illumina, and a historic moment to see the vice president get what's called the jab live on the air, and hopefully bring some confidence to the rest of the country, doctor. >> yeah, a great moment. i'm glad he did it on tv, and you think it will have an impact i think the vice president will provide reassurance to a lot of americans to go out and have confidence in taking this vaccine, both of these vaccines as well. this is a good thing >> at the same time this is happening, we have so many questions to ask you, dr. gottlieb, and we quizzed meg about this before, and she will want to get into this as well. the state of play between what's happening with the statements we're hearing from pfizer on one side over the last 24 hours, and the statements that we're hearing from hhs and alex azar who came on "squawk box" yesterday in terms of what is really happening here? >> right, well, there is no issue with the manufacturing manufacturing is going quite well the issue is

bets i think they're betting that more than one vaccine's going to get authorized >> reporter: scott gottlieb also on the board at pfizer. pfizer's ceo today said americans' vaccine skepticism only undermines public health >> it's been severely politicized, particularly in the u.s. that makes people confused and they don't know who to believe and what to believe. >> reporter: despite fewer shipments, president trump said other vaccine makers will ensure every american can get vaccinated by the spring, promising he will take action if enough doses aren't available. >> if we have any problems, we will be instituting the defense production act and we will make sure that we don't have any problems >> reporter: president trump also signing an executive order prioritizing americans ahead of other countries, though it's not clear how enforceable or practical that is. lester >> tom costello tonight. and tom, the numbers speak to the urgency 15 million americans have now contracted the virus. the drastic increase in serious cases is overwhelming medical centers everywhere miguel almaguer has more >> r

. >> reporter: former fda commissioner scott gottlieb now a pfizer board member points out that the fda also wanted to see two full months of safety data from clinical trials. >> that can take longer ultimately and that's why the fda process is moving a little bit more slowly >> reporter: authorization could be given by the end of the month and doses will be shipped within hours but in some places there remain concerns about distribution and storage, especially with pfizer's vaccine which requires the sub arctic temperatures. >> there's only about ten different hospitals in the entire state that has that capability. >> reporter: todd willard's health care company in rural kansas operates two hospitals, seven clinics and two nursing homes. none of his facilities can store the vaccine. he worries about staffing during the vaccinations. >> i better make sure i have enough that are taking care of all the patients we have but at the same time i have to make sure they're getting the vaccine. >> reporter: with hospitalizations growing it is a concern nationwide the vaccine requires two doses,

. >> reporter: former fda commissioner scott gottlieb warns a nationwide search in cases and deaths may not peek until january. >> i think by the end of the year we will be at probably about 300,000 deaths by the end of january we could be pushing 400,000 desperate visors vaccine is said to be reviewed for emergency use on thursday. but ernest the following week. >> but a second court of yes next year, we will have an vaccine for everyone. >> reporter: party president- elect joe biden expressed concern about the trump administration's vaccine strategy. digit but there is no detailed plan. that we have seen anyway. as you how you get the vaccine out of a container, into an injection syringe, and into someone's arm. >> reporter: health and human services secretary alex azar back on sunday -- with all respect, that is nonsense. we have copies of plans from the cdc, working with 54 public health jurisdictions across the country. >> reporter: operation speed chief adviser says he is confident the vaccines are safe. >> there are no serious adverse events associated with these vaccines. to the

commissioner scott gottlieb, and he joins us from west port, connecticut.ood morning to you. >> doctor: good morning. >> brennan: i want to start on the big picture. you forecasted last week we're not going to see peak hospitalizations for at least six weeks. the c.d.c. director put a more dire timeline on that, saying 60 to 90 days, and we'll have more deaths than on 9/11 or pearl harbor. how do you save lives at this point? >> doctor: the pressure is going to be on the health care system. they're not going to see peaks burdened on hospital resources probably until mid-january or late january. you're seeing some hopeful signs around the nation in terms of a slowing of new cases in the west and midwest. but you're seeing an acceleration in the east coast and the west country. so the entire country is not going through this pandemic at the same time. new york and california, califoa were a little later to have acceleration in cases, so they'll be later to peak. sometimes there is a slowing of cases in the parts of the country that were hit first, particularl

scott gottlieb, who's now a member of pfizer's board. and more vaccines do appear to be on the way. moderna is expected to be approved by the fda next week. johnson & johnson expecting the green light in january. terry mcsweeney, nbc bay area news. >> terry, thank you. phase three clinical trials were published today in a peer reviewed journal. and it confirmed the initial findings. how well it worked depended on dosage. two standard doses were 62% effective. but among participants who mistakenly received a low dose followed by a standard dose, the vaccine was 90% effective. some experts say because of the discrepancy in the doses the vaccine will likely take longer to be approved here in the u.s. by the fda. we have a lot more analysis and answers. in less than 10 minutes from now what exactly is herd immunity, and how do we achieve it. >> we ask an expert what happens next. >>> one more county on lockdown tonight. new covid restrictions kicked in from marin county. marin joining alameda, san francisco, contra costa and santa clara counties all following similar guidelines which me

scott gottlieb coming up.s morning. >>> and later, our special interview with warren buffet and goldman chs saceo david solomon on saving america's small businesses that's straight ahead. we're coming right back. in a land not so far away, people are saving hundreds on the most reliable network with xfinity mobile. they can choose from the latest phones or bring their own. and choose the data option that's right for them. they even get nationwide 5g at no extra cost. and since they are on the carrier rated #1 in customer satisfation, they live happily ever after. again, again! xfinity mobile. your wireless. your rules. your way to stay closer together. click, call, or visit an xfinity store today. >>> well, another day, another major departure from california. this time, it's oracle cofounder, larry ellison, he is the latest high profile silicon valley executive to move out of the state. ellison says he's moved to hawaii and will be working remotely oracle itself has announced a move out of california, relocat

scott gottlieb.ational captioning institute, which is responsible for its caption content and accuracy. visit ncicap.org james: week 13 in the nfl. boomer: titans are 15-6. they host the browns. nate: mayfield taking care of the ball. four straight games without interceptions. bill: cousins and vikings, 12 touchdowns and kirkd,

scott gottlieb he of course is the former fda commissioner and a cnbc contributor. the boards of both illumina and pfizer new this morning, his latest "wall street journal" op-ed asks the question and gives answers on who will get the covid vaccine first. doctor, welcome, it's good to see you. first of all, let's talk about this, if approval is given on thursday by in fda committee, how quickly do you think americans will actually start getting vaccinated here? >> very quickly, within days, so the supply that pfizer has said is going to be available for the month of december, and as you mentioned, i'm on the board of pfizer, is largely manufactured. that supply is available and ready to go. that will start shipping as soon as the authorization comes as it did in the uk. as soon as they got the authorization in the uk, trucks were rolling through the tunnel from europe into the united kingdom to deliver the supplies. they may vaccinate upwards of 800,000 people this week uk authorities have said that. we'll be ready to go quickly in the u.s. if the authorization come

scott gottlieb, former fda commissioner and cnbc contributor. served on the boards of illumina and pfizer. doctor, it's good to see you we have two sides of a brain, i guess, logical and emotional my first response to seeing the individual in the uk getting the vaccine, i was just really, i don't know, i was happy, emotionally, from that side of things, thinking, you know, okay if it does take seven months to get to everyone, seven months goes pretty fast am i wrong can i be happy >> well, look, i think we should be happy this is a major milestone, and the time that it took to develop this vaccine less than a year, really is historic, we went from a sequence strain on the virus to a fully developed vaccine that's been cleared by regulators at this point in well under a year that's a major milestone i think that supply in the u.s. will hopely rafully ramp quickl we get into 2021, and we'll have supply for the american people for the foreseeable future we're going to be in sort of a rationi rationing mode, assuming this vaccine does win authorizat

scott gottlieb.to the break take a look at this morning's winners and losers in the s&p 500. the winners, news corp. and nike, on the downside, a couple of stocks, including tesla, which was up big on friday it's not there anymore there's much bigger drops including occidental petroleum down t9%, apache, down just abou as much, and the cruise lines like carnival. "squawk box" will be right back. alright, okay. how's that? is that how you hold a mirror? [ding] power e*trade gives you an award-winning mobile app with powerful, easy-to-use tools and interactive charts to give you an edge, 24/7 support when you need it the most plus $0 commissions for online u.s. listed stocks. don't get mad. get e*trade and start trading today. that selling carsarvana, 100% online wouldn't work. don't get mad. get e*trade but we went to work. building an experience that lets you shop over 17,000 cars from home. creating a coast to coast network to deliver your car as soon as tomorrow. recruiting an army of customer advo

scott gottlieb suggested sunday it's likely because they didn't obtain consent in advance from nursinge vaccinated. >> very costly delay, 50,000 new infections in nursing homes every week right now, probably more than that. >> reporter: more than 76,000 residents in long-term care facilities have died from covid-19 and staff members. >> we trust the supplies are getting out quickly. >> reporter: some see cvs and walgreens r

scott gottlieb on the rollout. vaccine.and security official who was fired after rejecting president trump's false claims of widespread voter fraud. that's tomorrow on "morning joe." what if i sleep hot? ...or cold? introducing the new sleep number 360 smart bed. now temperature balancing, so you can sleep better together. can it help keep me asleep? absolutely, it intelligently senses your movements and automatically adjusts to keep you both effortlessly comfortable can it help with snoring? i've never heard snoring. exactly. no problem. and... done. so you can really promise better sleep? not promise. prove. it's the final days to save up to $700 on new sleep number 360 smart beds. plus, 0% interest for 48 months on all smart beds. ends thursday. >>> there are times when the city shows its true face. this is one of those times. and this is l.a. you see angels come in many ways. you believe in angels? ? that was a public service announcement from the non-profit group core. it stands for community organized relief effort, w

scott gottlieb has been warning americans since the early spring to get ready for the fall. dr. fauci has been warning since spring to get ready for the fall. everybody has said it's going to be the worst time ever. and what does the president of the united states do in april? he lies again through his teeth to the american people. he lies to members of his cult. he lies to people who believe his continued steady stream of lies, his fire hose of falsehoods instead of just listening to basic science and medicine. look at this clip. >> dr. robert redfield was totally misquoted in the media on a statement about the fall season and the virus. totally misquoted. >> you're accurately quoted? >> i was accurately quoted in "the new york post." >> he is saying please add to the guidelines getting your flu shot and -- >> you said there's a good chance that covid will not come back. >> we don't know. >> covid comes back, it's in a very small, confined area that we put out. >> well, the great thing is we'll be able to find it earlier this time. >> it might not come back at all, jeff. may no

todd: former fda chief scott gottlieb on this new strains and i think this is already in the us.nk of travel ban at this point will prevent this mutated strain from coming into the us but over time it will you leave all in ways that can obviate prior infection or vaccine so we probably need to adapt our vaccines over time. a lot to unpack, travel ban, changing the vaccine. break it down for us. >> in terms of changing the vaccine, these mrna vaccines are easy to adjust but we are nowhere near that. to the point about travel bans i think he is right, too late for that because the strain has spread to the very countries that are coming off travel in the same is true of this massive lockdown in the uk. that has tremendous cost associated with it and it is not clear it will decrease the spread since most of the spread occurs within households anyway. these things have to be looked at from a larger public health perspective. what are you gaining with these moves, that's why the united states has not cut off travel to the uk at this point because it is probably already here. shannon: y

former fda commissioner scott gottlieb warns that the surge may not peak until january.ncy use on thursday. and moderna's the following week. >>> i'm in the traffic center. as we hit the roadways on the east shore freeway brake lights heading into vallejo. crash there causing a bit of a backup on that westbound side of 80 so give yourself a few extra minutes. a couple of lanes are blocked not too far from the bridge. that's causing a bit of a backup. the nimitz freeway still a slow ride southbound. brake lights out of hayward, pocket of slowing into fremont. 37-minute drive time from ex spear experian to 235. >>> guflty offshore winds especially this morning with the peak winds with this offshore wind event. wind advisory until 11:00 a.m. rough and dangerous surf with the beach hazard statement and a hey surf warning for today. we are looking at the daytime highs unseasonably warm for this time of year. low 70s around the bay. mid-60s for the coast. low advanced non-small cell lung cancer can take away so much. but today there's a combination of two immunotherapies you c

scott gottlieb, of course, who we rely on so often, the story itself, but scott gottlieb, who is the board member of pfizer and somebody that we have relied on here at cnbc throughout this pandemic, for day in and day out good advice, spoke very candidly and sometimes a board member would take the fifth they say i'm not management, he did not do that, he went right at it and said, yeah, there was an option given to the u.s. government, it didn't take it. take a listen. >> pfizer did offer an additional allotment coming out of that plant, basically the second quarter allotment to the united states government, multiple times as recently as after the interim data came out, we knew this vaccine looked to be effective i think that the government made a bet that they are going to option or advance purchase vaccines from multiple manufacturers, they have agreements now with five or six manufacturers for about 100 million doses, each manufacturer they want to spread the bets >> spread the bets, jim, as opposed to potentially -- it was an option. that's what i don't understand it wasn't like

scott gottlieb and with that warning over the weekend and take a look at saturday with the president'sader event, and again, dr. gottlieb says this will get even worse than 284,000 people dead by the end of december and january. and it's going to get much worse before it gets better. this is what -- this is his life's work. and this is science talking. and this president is promulgating lies and bringing crowds together, knowing that that will make them sick and perhaps spread the coronavirus and even die. or spread it to others who will die. it's -- if you want to, you know, stop being shocked and think this is over, you can try, you can try to turn your head away from this. but republicans, you're going to live with this to the end of your lives that you let america down and you let more people die and you let this president go on a killing spree, superspreaders across the country so he could try to make this country something other than a democracy. and with that all facing the biden administration, the president-elect has picked his health team for when he takes over the country an

scott gottlieb as you know him well.ading floor in may so we can operate here in a safer environment. and it has been very, very successful so we're, you know, not looking to jump any queue with respect to vaccines, but we're encouraged by the progress the pharmaceutical companies have made this year it is astounding and we're looking forward to, you know, having seeing that impact on the economy more broadly very quickly. >> stacey, thank you it is good it see you today. we'll talk to you again soon. >> great to see you, becky enjoy the holidays >> take care >> when we come back, jim cramer's first take on the markets. stay tuned, everybody. you're watching "squawk box" and this is cnbc everyone wakes up every morning to a world that must keep turning. the world can't stop, so neither can we. because the things we make, help make the world go round. they make it cleaner, healthier, and more connected. it's what we build that keeps things moving forward. so with every turn, we'll keep building a world that works. >>> let

when pfizer offered them supplies beyond the 100 million doses, and the former fda commissioner scott gottliebrmed this, but the trump white house is denying the report. you have hhs secretariy alex azr saying we do still have option for another 500 million doses. here's my question to be fair in all this. the white house placed contracts with six different vaccine manufacturers, each guaranteed 100 million doses, astra-zeneca 300. what else were they supposed to do? was hedging their bets there the smart move? >> yes, they had to do that, right, there's a finite amount of funding and hope that we end up with a basket of vaccines so we have more than one available. however, i think they did drop the ball here because there were early signs about which of the vaccines looked likely to be ready, most likely to be efficacious in trials. now we're trying to play catch up to clean up the mess with an executive order being discussed that i don't think will do anything. pfizer is saying look, we gave you that option in the summer, you passed it up. now we sold 200 million doses of vaccine to the euro

i want to play for you how a former fda commissioner, scott gottlieb, who is also a pfizer board memberpfizer did offer an additional allotment coming out of that plant basically the second quarter allotment to the united states government multiple time

i talked to a lot of people about this, scott gottlieb, for example, former fda commissioner said it makes sense to get as many people some protection as possible initially. manufacture more doses for the second dose for those folks, get as much protection in the community right away. i talked to dr. fauci about this again as well and he has a different point of view. listen. >> does it make sense to you to take the 40 million projected doses by end of the year and give all those as first doses to people? >> we considered that, sanjay, and we decided that it would be more prudent not to do that, namely to get the real total degree of protection, not the 52%, but the 95% after the second dose. >> so there you have it. we're all learning together. i don't know that there's any absolute right answers here, but let me show you what he is talking about specifically, in between the first dose and second dose. there is some benefit. it is hard to study because it was just three weeks between the doses. but 52% benefit, it is better than 50% the fda originally wanted, but dr. fauci says bett

. >>> scott gottlieb, the former head of the fda, has been among those who have advocated, don't hold back half of these pfizer doses. if you're getting 50%, let's double the amount of people that are essentially got at least 50% of protection from this virus. what do you make of that idea and, look, i can see both sides of this argument, here we are talking about trust in vaccines, the last thing you might want to do is divvy up the protocol. >> it is an interesting idea that he has put forward and something that deserves discussion because we are in an emergency and i don't think we can let perfect be the enemy of the good. we could likely get more people vaccinated if we did that. but remember the data from the phase 3 clinical trial was based on a two-dose regiment so we don't know how effective a single dose will be. it's something that needs to be studi studied. there may be some hospitals that might do that with their health care workers. i've seen emails that i've gotten about that already. this might be something that some hospitals try based on their guidance. >> i'm curious

>> reporter: scott gottlieb, the former fda commissioner who is on the board of pfizer said pfizer doses have been promised to other countries. >> some of was promised to other countries after it was offered multiple times to the united states. >> reporter: we have now learned the president's other attorney jenna ellis has tested positive for coronavirus. according to what she told associates today. she has been crisscrossing the country with rudy giuliani who was hospitalized coronavirus on sunday but he gave an interview to a radio station he believes he could be released from the hospital as soon as tomorrow. he confirmed he has been taking that cocktail steroid similar to the one president trump took when he was in the hospital with coronavirus that is typically reserved, according to medical experts, for the more severe cases of covid-19. >> there does seem to be a special exemption made for friends of the president as well as the president when it comes to getting this highly potent cocktail. >>> joe biden introduced key members of his health team and laid out a three-step plan to

scott gottlieb, spoke with usa today editorial board and he thinks, by february or march, the virus will collapse and go quiet over the spring or summer. we'll see cases get reported but we are not going to see major spread. there'll be -- there will be sporadic outbreaks. i fully expect kids will be back in summer camp, and people will be having barbecues again, outdoors. now, that would be welcome news. is that how you see it? >> well, it's certainly an optimistic take. and -- and we do know that being indoors does drive spread of the virus. whether we'll actually see the virus collapse in the spring or just a drop in transmission, i do think we will see a decrease in transmission. it's just hard to predict how dramatic that will be. >> the fda is meeting, on thursday, to discuss emergency-use authorization of the pfizer vaccine. once they approve it, should the president-elect be at the top of the list to get it? >> well, i think it's important for as many of our elected officials to step up and demonstrate that we endorse the fda-authorization process. that, if it is, in fact, grante

scott gottlieb, that the administration passed multiple times when presented with the opportunity to buy additional doses of the pfizer vaccine. even in the words of gottlieb, after there were initial promising results associated with it. so the u.s. ended up buying about 100 million of these doses, which is good to vaccinate about 50 million people, because of course it's two doses you'll need for full vaccines treatment for visits. for comparison, the european union purchased 200 million doses. so right now, as the u.s. is now seeing these promising results likely to be approved, emergency use approval authorization later this week, it may be not until june before the u.s. is able to purchase more of that vaccine, because so much of it has been snapped up by those other foreign countries to this point. the white house pushes back on this, they insist it's false, they say that the white house is in negotiation with multiple agreements with many different vaccine manufacturers right now. but it does raise a lot of questions even as the president today is going to sort of have a victo

scott gottlieb telling cnbc yesterday the trump administration turned down pfizer's offer for an additionals an initial report by the "new york times" that the trump administration passed on a chance to secure more of the vaccine from the manufacturer. great. >>> and joining us now with a look at axios a.m., alexi, good morning. great to see you. what's your "one big thing" this morning? >> hey, kasie. good morning to you. code's "one big thing" is about president-elect biden's white house. likely to start out operating with what is described as a skeleton staff. few staff members actually working in the west wing, working on the white house grounds when joe biden is inaugurated and takes office in january of next year as a way to really keep him healthy. he's, of course in a high-risk group personally and politically for this virus. and his team is taking extra precautions and thinking through extra precautions after they've seen the way in which president trump and the current occupants of the white house have really taken a cavalier approach to safety measures and enacting those things b

scott gottlieb. also a member of the board of directors of pfizer. dr. scott, let's talk about moderna. how significant is this, and how will the moderna vaccine work alongside pfizer's? >> well, look, it's significant. you now have two manufacturers in the market producing significant supply. the united states government has secured 200 million doses of moderna's vaccine between now and june. that's going to be delivered over the first and second quarter of next year. they're going to be delivering up to 20 million doses this year. this will be a lot of supply coming into the market. the vaccines are very similar. they work through a very similar vaccine, mrna vaccine. you're giving the patient a genetic sequence that codes for the production of a protein found on the surface of the coronavirus. the spike protein. and when that genetic sequence is taken up by our bodies, our bodies start to produce that protein. it reads the genetic sequence and produces the protein. and once that protein is in our bodies our immune system kicks in and develops antibodie

the former head of the fda scott gottlieb is one of those that advocates, hey, don't hold back for secondwe know people need to get them, but, hey, let's do as much mitigation as we can right now. and getting more people at 62% is better than half the people at 90% or is it? what say you to that? >> well, i actually continue to support the idea of individuals getting both doses. i think that long-term we surely know that that will be better. in the short-term, even, i think that we have to be careful to assume too much benefit from one shot and then out. so i think that the fda's approval of this vaccine under emergency use authorization with two doses, with the cdc's acip committee recommendation of two doses, i support that and think that's where we should be going right now. >> the moderna and pfizer vaccines to a lot of people they seem very similar. obviously one is a lot harder to travel than the other. are there any other discernible differences between the two that folks should be aware of? >> at this point, the most important number, the one number we want to use to measure the s

scott gottlieb raised this yesterday as well, is that given that there's not enough vaccine doesn't make sense, for example, to take the 40 million doses and say let's just inoculate 40 million people right out of the gate and wait for manufacturing to catch up for those second shots. i can tell you right now that that is not the plan from operation warped speed. they essentially want to take the 40 million doses g ahead and use 20 million initially, keep the other 20 million in cold storage and use those additional 20 million for those same patients. you could see sort of the dilemma here. we're going through this realtime. there is no magical answer here and people have differing points of view on this, but right now at least according to moncef and operation warped speed they're going to hang on to the doses and keep those for those who got the first shot. the other thing in the document that i think is worth pointing out, another big question, if you have had coronavirus and you think you have antibodies should you still go ahead and get vaccinated? what this document seemed to sugge

and i think it was interesting insight from scott gottlieb but not part of the trump administration. but his take on this being that the administration wants to hold back some doses so we make sure when you get to the point where everyone needs that second dose in three or four weeks that the vaccine's there for them. so, just really highlighting the very complex logistical challenge we're going to be facing because this is just the very beginning right now. >> so the biden team, shannon, according to your reporting, is worried about the process getting slowed down right now, and that carrying over to his administration. what specifically are they worried is going to continue on between now and then? >> i mean, there's a lot of different expectations i hear when i talk to those working with "operation warp speed" and when i talk to those who are advising the biden team in some capacity. "operation warp speed" is laying out a very aggressive time line that by late february the general population, the healthy population out there could start getting this vaccine by march or april we co

i'm sure you saw the former fda commissioner, scott gottlieb who is on pfizer's board confirmed to cnbc yesterday that the administration turn down the chance to lock in more doses, presumably betting on other companies to win approval for their vaccines. but right now with just two in the immediate pipeline, could we be heading for a serious shortage of shots? >> i think we should expect hiccups and these essential -- these issues that we're having with the rollout of these vaccines. these are manufacturers that are going to hit supply chain constraints. i think these are iet stems and issues that are certainly not new. so i think this is something we need to understand this is an entire process. there's going to be bumps and bruises along the way. there are going to be hiccups. but we are do know that we're not putting all our eggs in one basket. there's going to be multiple other vaccines that will be made available, specifically coming into next year in quarter one. we'll probably have four to five different vaccines authorized by then. we'll have more of a supply for the general po

former food and drug administration commissioner scott gottlieb says he believes the variant is probablythe u.s. and could be spreading rapidly. wear a mask, folks. >>> meanwhile, countries across the european union have begun to roll out the coronavirus vaccine for their 450 million residents, despite concern that many bones be able to get vaccinated due to limited supply. the eu ordered 200 million doses of the pfizer/biontech vaccine, and they are being equally divided among the 27 states that make up the union. more than 350,000 people in the region have died from covid-19 since its first fatality was reported in france back in february. >>> and the massive campaign to get americans vaccinated has kicked off to a slower start than we expected. just over 1 million doses of the vaccine have been utilized out of the 9.5 million doses that have been distributed nationwide, according to the centers for disease control and prevention. however, health officials remain optimistic that 100 million people will get vaccinated by march. the first doses of the vaccine were distributed by pfizer o

. >> scott gottlieb who is a former head of the fda, he proposed the idea that said, hey, with the pfizertwo shots, don't hold back additional dosages yet. vaccinate as many people you can with the first shot and basically hope you get enough vaccine to properly do the second shot when you can. versus, you know, correctly deciding -- versus not assuming you're going to have that supply in time and holding it back. where are you on that question? i get the argument. if this is an emergency, hey, 50% is better than nothing and you're doubling the amount of people. where is your head on that, sir? >> i disagree with that strategy. i think we need to fully immunize the persons with the vile vials that we have and get additional vials to immunize the rest of the population. we know partial protection after the first dose. but having partial dose may make it worse since we don't know if after the first dose does not transmit transmission. my opinion is to vaccinate those with two shots. >> there is a lot of assumption that the fda is going to approve the pfizer maybe tomorrow or the day after t

scott gottlieb now former head of the fda, a pfizer board member, cnbc contributor, thank you. should we anticipate more supply issues like these? >> well, look, i certainly hope not. the issue is that for all the companies, for both moderna and pfizer, they ramp up week from week maybe the first week you might produce 5 million, the second 10 million then the third 15 million and grows from there if you take the third week that would have been in 2020, now you push it out in 2021 your supply is cut in half the supply moves quickly as you move out and the more you push out the time frame in 2021 by a week or two weeks you have bless supply in 2021 i hope we will have adequate supply that will ramp quickly but hopefully she's these do get in the market. another one on the 10th and 17th to consider both. >> you probably heard dr. fauci saying that he believed in the united kingdom they rushed the process of getting this through and then later walked it back and said he had good faith in the uk when talking to the bbc his point was americans are already skeptical about these virus

you wrote an op-ed in "the wall street journal" with a former -- fellow former fda commissioner scott gottlieb and you're calling for the increased use of antibody treatment. we've been so obsessed, rightfully so, with the distribution of this vaccine in the last two weeks that i want to get a better idea, what drugs are you talking about and for what purpose? >> ali, we've been rightfully focused on vaccines. this is tremendously good news. that's the way to control the virus over time. but right now we're also living through a very big and unprecedented surge in cases. and what the monoclonal antibodies do, these are essentially man-made antibodies that give to you, to patients who have been exposed to covid, have covid in the early stages, that antibodies of a vaccine would normally make you produce on your own. this is kind of a bridge to a vaccine for people who are at very high risk of complications. the challenge is it's a new treatment. it takes some new steps to get it available for widely and we are seeing a big mismatch between the amount of monoclonal antibodies available and the a